Health Technology · Pharmaceuticals: Major · NSE: UNICHEMLAB · data 2026-10-09

Unichem Laboratories Limited

Health check: Strong (7.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹531.1

Market cap

₹3,725 cr

P/E

12.3

P/B

—

ROE

9.8%

ROCE

-0.5%

Debt / equity

0.18

Dividend yield

0.00%

1-year return

14.2%

52-week high

₹687.2

52-week low

₹278.2

Operating margin

4.6%

Growth

Revenue (last 12 months)	₹2,308 cr
Net profit (last 12 months)	₹305 cr
Sales growth, 3 years (yearly)	18.1%
Profit growth, 3 years (yearly)	—

Similar companies

SMS Pharmaceuticals Limited (SMSPHARMA) · Gufic Biosciences Limited (GUFICBIO) · Zota Health Care Ltd. (ZOTA) · Aarti Drugs Limited (AARTIDRUGS) · Kwality Pharmaceuticals Ltd (KPL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open UNICHEMLAB in NSE Scanner →